The present study aimed to examine the effect of astilbin, a flavanoid, on liver injury. When
administered during the effector but not induction phase, astilbin significantly decreased the …

The aim of this study was to evaluate the effect of astilbin on concanavalin A (Con A)-
induced hepatitis, a T cell-dependent model of liver injury. Con A administration resulted in a …

Indole‐3‐carbinol (I3C), a major indole compound found in high levels in cruciferous
vegetables, shows a broad spectrum of biological activities. However, few studies have …

Background and Aim: Tanshione IIA (TSN) is the major active component of Salvia
miltiorrhiza, a traditional Chinese Medicine. TSN protects against antioxidant-induced liver …

Background and Purpose Liver diseases are mostly accompanied by inflammation and
hepatocyte death. Therapeutic approaches targeting both hepatocyte injury and …

Background: Hepatic ischemia/reperfusion (I/R) injury to the liver is a significant cause of
morbidity and mortality following liver surgery, trauma, and hemorrhagic shock. It was …

Fumigaclavine C, an alkaloidal metabolite, was produced by Aspergillus fumigatus (strain
No. CY018). This study examined the effect of this compound on concanavalin A (Con A) …

Recently, an increasing number of studies suggest that oxidative stress and inflammation
are associated with hepatocellular injuries. Thus, we aimed to evaluate the potential …

Background/Aims: Silibinin is the major pharmacologically active compound of the Silybum
marianum fruit extract silymarin. Its well-known hepatoprotective activities are mostly …

Liver fibrosis and cirrhosis may be reversible, possibly through the selective clearance of
activated hepatic stellate cells/myofibroblasts by apoptosis. Hepatic stellate cells …